22 June 2023
The Continuous Mortality Investigation (CMI) has released the latest annual update to the CMI Mortality Projections Model, CMI_2022.
Standardised mortality rates in England & Wales in 2022 were on average 3% lower than in 2021. However, mortality in 2020 to 2022 was significantly higher than before the coronavirus pandemic. Compared to mortality in 2019, mortality in 2020 was 14% higher, mortality in 2021 was 9% higher, and mortality in 2022 was 6% higher.
The CMI Model is used by UK pension schemes and insurance companies which need to make assumptions about future mortality rates. While mortality experience in 2020 and 2021 will affect actuarial calculations, mortality in both of those years was exceptional and is unlikely to be indicative of future mortality. For this reason, the CMI places no weight on the data for 2020 and 2021 in the core version of the model.
While mortality in 2022 has also been higher than pre-pandemic levels, it has been less volatile and may be indicative of future mortality to some extent. Given that, and following a consultation with users of the model, the CMI has placed 25% weight on data for 2022 when calibrating CMI_2022 while still placing no weight on data for 2020 and 2021.
CMI_2022 produces cohort life expectancies at age 65 that are about 7 months lower for males and about 6 months lower for females, than in the previous version of the CMI model, CMI_2021.
Cobus Daneel, Chair, CMI Mortality Projections Committee, said:
“Mortality rates can be volatile from year to year, but they tend to decrease over time. It is unusual to see three consecutive years where mortality rates are so much higher than the recent trend, even during prior pandemics such as the Asian Flu (1957/58) and the Hong Kong Flu (1968/69). We have to go back to World War II to find a period as unusual as 2020-2022 relative to the preceding five-year average.
“The exceptional nature of mortality in 2020 or 2021 due to the coronavirus pandemic meant that we placed no weight on mortality experience for those years. However, more recent data has been less volatile and suggests that mortality may remain higher than our expectations before the pandemic for some time. We have given partial weight to data for 2022 in the CMI Model, which leads to lower life expectancies.
“We made this change after a consultation process and received support from users in the pensions and insurance industry. However, we still encourage users to consider adjusting the model’s parameters to reflect their own portfolios and their views of the impact of the pandemic.”
The data used to calibrate CMI_2022 has been revised to reflect results of the 2021 census. We have used the ONS population estimates for 2021, which take account of the census, and we have revised our population estimates for 2012-2020, the period between the two most recent censuses, to be consistent with these. The ONS has not yet published its own revised estimates for 2012-2020. The revised population estimates for 2012-2021 account for around 1 month of the total 6-7 month fall in life expectancies at age 65 noted above.
Chart A shows standardised mortality rates (which allow for consistent comparisons of mortality over time) in the general population of England & Wales from 1981 to 2022. Standardised mortality rates nearly halved between 1981 and 2019, although the fall in mortality rates was modest between 2011 and 2019. Mortality was notably higher in 2020, 2021 and 2022 than in 2019, due to the coronavirus pandemic and its repercussions.
Chart A: Standardised mortality rates in England & Wales since 1982
Chart B shows the progression of cohort life expectancy at age 65 in successive versions of the CMI Model. The figures for CMI_2022 are around two years lower than in the first version, CMI_2009.
Chart B: Cohort life expectancies as at 1 January 2023 at age 65 from CMI_2022 and earlier versions
For more information on the CMI Mortality Projections Model, CMI_2022, please see the FAQs.
From April 2020 to date, the CMI Mortality Projections Committee has produced a regular mortality monitor with a focus on ‘excess deaths’ during the pandemic.
~ENDS~
Sonia Sequeira, Media Relations Manager, IFoA
Tel: 07525 592 198
Email: sonia.sequeira@actuaries.org.uk
1. CMI Mortality Projections Model CMI_2022 - Frequently asked questions. https://www.actuaries.org.uk/mortality-improvements-and-cmi-2022-frequently-asked-questions-faqs June 2023.
2. Cohort life expectancy allows for assumed future changes in mortality rates. As future changes are unknown, it is a subjective measure. It is typically used by actuaries who need to use realistic assumptions about the lifespan of pension scheme members or insurance company policyholders. In contrast, period life expectancy only allows for changes in mortality rates to date and makes no allowance for future changes. It is an objective measure that is often reported by the Office for National Statistics.
3. Because mortality rates are higher at older ages, changes in the age distribution of a population can lead to apparent changes in average mortality rates, even if mortality rates at each age do not change. A standardised mortality rate (SMR) can be thought of an average mortality rate for a group of lives, assuming that it has a standard age profile. This enables us to make a consistent comparison of mortality rates over time and between groups. We use the age profile of the 2013 European Standard Population for ages 20 to 100.
4. The CMI Mortality Projections Model (the “CMI Model”) was introduced in 2009 to replace previous projections and has been updated on a broadly annual basis since then. It is based on mortality data for the population of England & Wales, published by the Office for National Statistics.
5. The CMI Model is typically used by UK pension schemes and insurance companies which need to make assumptions about future mortality rates. The Model does not provide an assumption around long-term mortality improvements, requiring users to make their own assessment.
6. Life expectancy for different groups, such as particular pension schemes and groups of policyholders, can vary considerably, and the CMI encourages users of the CMI Model to make appropriate assumptions for the purpose that it is being used for.
Continuous Mortality Investigation Limited (‘the CMI’) is wholly owned by the Institute and Faculty of Actuaries but has an independent executive and management.
The CMI’s mission is to produce high-quality impartial analysis, standard tables and models of mortality and morbidity for long-term insurance products and pension scheme liabilities on behalf of subscribers and, in doing so, to further actuarial understanding.
The Institute and Faculty of Actuaries (IFoA) is a royal chartered, not-for-profit, professional body.
Research undertaken by the IFoA is not commercial. As a learned society, research helps us to fulfil our royal charter requirements to further actuarial science and serve the public interest.
Actuaries provide commercial, financial and prudential advice on the management of a business’s assets and liabilities, especially where long term management and planning are critical to the success of any business venture. They also advise individuals, and advise on social and public interest issues.
Members of the IFoA have a statutory role in the supervision of pension funds and life insurance companies. They also have a statutory role to provide actuarial opinions for managing agents at Lloyd’s of London.
Members are governed by the Institute and Faculty of Actuaries. A rigorous examination system is supported by a programme of continuing professional development and a professional code of conduct supports high standards reflecting the significant role of actuaries in society.
The IFoA is available to provide independent expert comment to the media on a range of actuarial-related issues, including COVID-19 and its long term consequences, mortality, pensions, life and general insurance, health and care, finance and investment, climate change and sustainability, systems thinking, uncertainty and judgement, and risk management.